How to approach the treatment of younger patients with MPN

Lindsay Rein, MD, Duke University Medical Center, Durham, NC, shares how she approaches the treatment of younger patients with myeloproliferative neoplasms (MPN). Dr Rein mentions the importance of assessing whether treatment is necessary, selecting the most suitable agent, and considering whether the patient is a candidate for stem cell transplantation (SCT). This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.